Role of ADAMTS-13 in platelet adhesion in flow: Methods for diagnosis of thrombotic thrombocytopenic purpura

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 1-2, 2006, Pages

  Shenkman, Boris ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

ADAMTS13; Platelet adhesion thrombotic thrombocytopenic purpura; Thrombotic microangiopathies; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; VON WILLEBRAND FACTOR;

CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD RHEOLOGY; DIMERIZATION; HUMAN; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE ADHESIVENESS;

ADAM PROTEINS; DIMERIZATION; HEMORHEOLOGY; HUMANS; PLATELET ADHESIVENESS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 33748472158     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion. Blood 1996; 87: 4235-4244.
2. Denis C, Baruch D, Kietly CM, Ajzenberg N, Christofe O, Meyer D. Lokalization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Arterioscl Thromb 1993; 13: 398-406.
3. Ruggeri ZM. New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 1994; 31: 229-39.
4. Manucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-2735.
5. Dong JF, Whitelock J, Bernardo A, Ball C, Cruz MA. Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow. J Thromb Haemost 2004; 2: 1460-1466.
6. Hovinga JA, Studt JD, Alberio L, Lammle B. Von Willebrand-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. Semin Hematol 2004; 41: 75-82.
7. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenhaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 1998; 339: 1578-1584.
8. Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 2005; 105: 1085-1093.
9. Pimanda JE, Ganderton T, Maekawa A, Yap CL, Lawler J, Kershaw G, Chesterman CN, Hogg PJ. Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. J Biol Chem 2004; 279: 21439-21448.
10. Lopez JA, Dong JF. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin Hematol 2004; 41: 15-23.
11. Dong JF, Moake JL, Nolasco L, Bernardo A, Arcencaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-4039.
12. Tsai HM, Sussman JJ, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994; 83:2171-2179.
13. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Turner N, Berndt MC, Anvari B, Lopez JA, Dong JF. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150-2156.
14. Moake JL. Thrombotic microangiopathies. N Eng J Med 2002; 347: 589-600.
15. Bernando A, Ball C, Nolasco L, Moake JF, Dong JE. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004; 104: 100-106.
16. Reiter RA, Rnobl P, Varadi K, Turecek (?) PL. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 2003; 101: 946-948.
17. Aizenberg N, Denis CV, Veyradier A, Girma J-P, Meyer D, Baruch D. Complete defect in VWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy. Thromb Haemost 2002; 87: 808-811.
18. Moore JC, Hayward CPM, Warkentin TE, Kelton JG. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001; 98: 1842-1845.
19. Veyradier A, Obert B, Houllier A, Meyer D, Girma J-P. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-1772.
20. Furlan M, Robles R, SolenthalerM, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-3103.
21. Obert B, Tout H, Veyradier A, Fressinaud E, Meyer D, Girma JP. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost 1999; 82: 1382-1385.
22. Gerritsen HE, Turecek PL, Schwarz HP, Lammle B, Furlan M. Assay of von Willebrand factor (VWF)-cleaving protease based on decreased collagen binding affinity of degtadedVWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999; 82: 1386-1389.
23. Bohm M, Vigh T, Scharrer I. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Ann Hematol 2002; 81: 430-435.
24. Kokame K, Matsumoto M, Fujimura Y, Miyota T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 2004; 103: 607-612.
25. Zhou W, Tsai HM. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations. Thromb Haemost 2004; 91: 806-811.
26. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
27. Shenkman B, Inbal A, Tamarin I, Lubetsky A, Savion N, Varon D. Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition. Br J Haematol 2003; 120: 597-604.